© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Tim Horn speaks with researcher Nancy Crum-Cianflone, MD, MPH, about methicillin-resistant Staphylococcus aureus (MRSA)
Tim Horn speaks with Nancy Crum-Cianflone, MD, MPH, a researcher and physician at the Naval Medical Center in San Diego.
Skin infections caused by drug-resistant staph are more common and more likely to recur in people living with HIV, according to three new stud...
The incidence of pulmonary hypertension—high blood pressure in the arteries that supply the lungs—is significantly higher in HIV-p...
A handful of presentations at the 2008 joint meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the I...
More than 10 years after combination HIV treatment was heralded as the one and only way to treat HIV, data continue to emerge suggesting that...
Twenty-five years into the HIV epidemic, has the virus evolved to become more dangerous? This was the question asked by a research team headed...
Long-term follow-up data from a study indicate higher response rates with Norvir (ritonavir)-boosted Reyataz (atazanavir) compared with Kaletr...
Once-daily Norvir (ritonavir)-boosted Prezista (darunavir) is more likely to keep viral loads undetectable in HIV-positive people starting ant...
Positive early results from a Phase II clinical trial of intravenous (IV) PRO 140, an experimental HIV entry inhibitor.
Once-daily RDEA806, an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) being developed by Ardea Biosciences, appears highl...
New research from a team of U.S. and Canadian researchers suggests that HIV-positive people have less risk of dying if they start ARV...
Selzentry (Celsentri; maraviroc) is comparable to Sustiva (efavirenz) in HIV-positive patients starting antiretroviral (ARV) treatment for the...
Isentress (raltegravir) appears to work just as well as Sustiva (efavirenz), with fewer drug-related side effects, in HIV-positive patients st...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
